Galderma’s Restylane Shaype Approved in Mexico for Chin and Jawline Enhancement

November 16, 2026

Galderma Est. 1981

Galderma Aesthetics announced that Restylane Shaype is now approved in Mexico for temporary augmentation in the chin area and improvement of jawline definition. The approval marks the product’s first jawline indication worldwide.

Restylane Shaype is a hyaluronic acid (HA) filler, developed to deliver a unique bone-mimicking effect and enable natural-looking structural enhancement without surgery.

According to Galderma, the approval was supported by clinical data evaluating aesthetic improvement in the chin and jawline areas. The company said the product is designed to provide support and projection while maintaining a natural appearance and facial movement.

Restylane Shaype is not currently approved for use in the United States.

Become a member

Get the tools you need to succeed in the medical spa industry.

Related
    • AestheticsPro Supports AmSpa Members as Platinum Vendor Affiliate
    • Hims & Hers Plans Launch of Peptide Treatments Following Federal Policy Shift
    • FDA Requires New Safety Warning on GLP-1 Medications for Rare Eye Condition
    • Stella Advisory Becomes Silver Vendor Affiliate with the American Med Spa Association
    • Allergan Aesthetics Reports Aesthetic Treatment Satisfaction in Patients Using GLP-1s